- Home
- AXSM vs LEU Comparison
AXSM vs LEU Comparison
Compare AXSM & LEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- LEU
- Stock Information
- Founded
- AXSM 2012
- LEU 1998
- Country
- AXSM United States
- LEU United States
- Employees
- AXSM N/A
- LEU N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- LEU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- AXSM Health Care
- LEU Industrials
- Exchange
- AXSM Nasdaq
- LEU Nasdaq
- Market Cap
- AXSM 5.1B
- LEU 4.2B
- IPO Year
- AXSM 2015
- LEU 1998
- Fundamental
- Price
- AXSM $121.15
- LEU $208.93
- Analyst Decision
- AXSM Strong Buy
- LEU Buy
- Analyst Count
- AXSM 16
- LEU 11
- Target Price
- AXSM $176.56
- LEU $194.80
- AVG Volume (30 Days)
- AXSM 568.1K
- LEU 1.6M
- Earning Date
- AXSM 08-04-2025
- LEU 08-05-2025
- Dividend Yield
- AXSM N/A
- LEU N/A
- EPS Growth
- AXSM N/A
- LEU 10.12
- EPS
- AXSM N/A
- LEU 6.16
- Revenue
- AXSM $495,033,000.00
- LEU $436,900,000.00
- Revenue This Year
- AXSM $61.62
- LEU $3.52
- Revenue Next Year
- AXSM $59.02
- LEU $8.01
- P/E Ratio
- AXSM N/A
- LEU $33.90
- Revenue Growth
- AXSM 69.83
- LEU 12.72
- 52 Week Low
- AXSM $75.56
- LEU $34.91
- 52 Week High
- AXSM $139.13
- LEU $264.90
- Technical
- Relative Strength Index (RSI)
- AXSM 71.81
- LEU 54.76
- Support Level
- AXSM $115.99
- LEU $162.10
- Resistance Level
- AXSM $120.50
- LEU $229.96
- Average True Range (ATR)
- AXSM 3.34
- LEU 14.37
- MACD
- AXSM 1.49
- LEU -1.65
- Stochastic Oscillator
- AXSM 98.22
- LEU 55.82
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About LEU Centrus Energy Corp.
Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.